HUSSEIN TAWBI to Pyrrolidines
This is a "connection" page, showing publications HUSSEIN TAWBI has written about Pyrrolidines.
Connection Strength
0.154
-
Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors. JCI Insight. 2018 02 22; 3(4).
Score: 0.154
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.